The serum concentration of bactericidal antibiotics (rifampicin, cephaloridine) in relation to the low resistance period in experimental infections. Immunological investigations in experimental chemotherapy. V.
D000818:Animals; D002509:Cephaloridine / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000276:immunology; D007239:Infections / Q000276:immunology*; D007709:Klebsiella / Q000187:drug effects; D007710:Klebsiella Infections / Q000188:drug therapy / Q000276:immunology; D008089:Listeria monocytogenes / Q000187:drug effects; D008088:Listeriosis / Q000188:drug therapy / Q000276:immunology; D051379:Mice; D010325:Pasteurella / Q000187:drug effects; D010326:Pasteurella Infections / Q000188:drug therapy / Q000276:immunology; D011008:Pneumococcal Infections / Q000188:drug therapy / Q000276:immunology; D012293:Rifampin / Q000008:administration & dosage / Q000097:blood* / Q000627:therapeutic use; D012481:Salmonella Infections, Animal / Q000188:drug therapy / Q000276:immunology; D012486:Salmonella typhimurium / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000276:immunology; D013210:Staphylococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects
D002509:Cephaloridine; D012293:Rifampin